跳至主要内容
临床试验/NCT02123667
NCT02123667已完成不适用

AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS); Multinational, Multicentre, Non-pharmacological Intervention, Cross-sectional and Longitudinal Study.

Chiesi Farmaceutici S.p.A.44 个研究点 分布在 8 个国家目标入组 872 人开始时间: 2014年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
872
试验地点
44
主要终点
To determine the role of small airways abnormalities in the clinical manifestations of asthma.

研究概览

简要总结

Multinational, multicentre, non-pharmacological intervention, cross-sectional and longitudinal study.

详细描述

Large non pharmacological studies on Small Airways Disease

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Asthmatic patient inclusion criteria
  • Male or female patients aged ≥ 18 and ≤ 65 years, who have signed an Informed Consent form
  • Clinical diagnosis of asthma f
  • Positive response to methacholine challenge test
  • Positive response to a reversibility test or
  • Peak Flow variability (i.e. highest - lowest PEF over the day/mean value of the two, × 100) > 20% or
  • Documented response (defined as ΔFEV1 ≥ 12% and ≥ 200 mL) after a cycle (e.g., 4 weeks) of regular maintenance anti-asthma treatment.
  • Patients with stable asthma.
  • Current smoker, ex-smoker or lifelong non-smoker Healthy subject inclusion criteria
  • 1. Male or female patients aged ≥ 18 and ≤ 65 years
  • No clinical history of asthma or COPD
  • Current smoker, ex-smoker or lifelong non-smokers
  • Normal spirometry
  • Normal airways responsiveness Asthmatic patient

排除标准

  • Cigarette smoking > 10 packyears
  • diagnosis of COPD
  • Asthma exacerbation in the 8 weeks prior to baseline visit
  • Clinical or functional uncontrolled respiratory, haematological, immunologic, renal, neurologic, hepatic, endocrinal or other disease, or any condition that might compromise the results or interpretation of the study.
  • Pregnant or lactating women
  • Participation in an interventional clinical trial <12 weeks preceding baseline visit
  • Inability to comply with study procedures.
  • Alcohol or drug abuse. Healthy subject exclusion criteria
  • 1. Cigarette smoking history > 10 packyears
  • Diagnosed upper and/or lower respiratory disease(s).
  • Clinical or functional uncontrolled haematological, immunologic, renal, neurologic, hepatic, endocrinal or other disease, or any condition that mightp compromise the results or interpretation of the study.
  • 4. Pregnant or lactating women
  • Participation in an interventional clinical trial <12 weeks preceding baseline visit
  • Inability to comply with study procedures.
  • Alcohol or drug abuse.

研究组 & 干预措施

Asthmatic patients

asthmatic patients 18 to 65

Healthy volunteers

Volunteers 18 to 65

结局指标

主要结局

To determine the role of small airways abnormalities in the clinical manifestations of asthma.

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (44)

Loading locations...

相似试验